Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Quercitrin is a naturally occurring glycoside formed from the flavonoid quercetin and the deoxy sugar rhamnose. It is classified as a flavonoid glycoside and can be found in various plants such as Tartary buckwheat (Fagopyrum tataricum), North American white oak (Quercus alba), English oak (Quercus robur), Nymphaea odorata and Taxillus kaempferi[8][10]. Quercitrin has been investigated primarily as a dietary supplement due to its antioxidant properties. In the body or in vitro via enzymatic hydrolysis by quercitrinase it yields L-rhamnose and quercetin[8]. Its mechanism of action is believed to be related to its antioxidant activity—scavenging free radicals—and potential anti-inflammatory effects through modulation of cellular signaling pathways associated with oxidative stress. There are no approved pharmaceutical indications for quercitrin; most research focuses on its role as an antioxidant or dietary supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on quercitrin.